FDA approval clears the path for drug market entry, driving future regulatory focus for major pharmaceutical companies.

The entities involved

• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
• Pfizer →

  American multinational pharmaceutical and biotechnology corporation

  • Dave Long trained at Fort Knox after graduating from Boardman High School and later worked for Pfizer.Mon 05:00
  • MarketBeat's screener has identified a list of dividend stocks.Sun 22:22
• Eli Lilly and Company →

  American pharmaceutical company

  • ExxonMobil, Berkshire Hathaway, and Eli Lilly are top holdings in the Avantis ETF.Mon 17:18
  • The FDA approved Olumiant for pediatric indications on September 1, 2026.Mon 05:59

Related events

• The FDA is currently reviewing new drug applications for market entry.Jun 22
• The FDA is monitoring drug industry practices and pricing, utilizing studies published by JAMA.Sep 10
• The FDA recommended advancement for a new drug application submitted by a company.Jun 8
• FDA clearance drives market expansion and coverage for NeurAxis, Inc.Jun 7
• Eli Lilly and Company plans to submit a drug candidate to the FDA for review and approval.Aug 5